Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rifampin and rifabutin and their metabolism by human liver esterases.
Jamis-Dow CA, Katki AG, Collins JM, Klecker RW. Jamis-Dow CA, et al. Xenobiotica. 1997 Oct;27(10):1015-24. doi: 10.1080/004982597239994. Xenobiotica. 1997. PMID: 9364739
Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.
Klecker RW, Jamis-Dow CA, Egorin MJ, Erkmen K, Parker RJ, Stevens R, Collins JM. Klecker RW, et al. Among authors: jamis dow ca. Drug Metab Dispos. 1994 Mar-Apr;22(2):254-8. Drug Metab Dispos. 1994. PMID: 7912177
Metabolism of rifabutin and its 25-desacetyl metabolite, LM565, by human liver microsomes and recombinant human cytochrome P-450 3A4: relevance to clinical interaction with fluconazole.
Trapnell CB, Jamis-Dow C, Klecker RW, Collins JM. Trapnell CB, et al. Antimicrob Agents Chemother. 1997 May;41(5):924-6. doi: 10.1128/AAC.41.5.924. Antimicrob Agents Chemother. 1997. PMID: 9145845 Free PMC article.
Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid.
Trapnell CB, Klecker RW, Jamis-Dow C, Collins JM. Trapnell CB, et al. Antimicrob Agents Chemother. 1998 Jul;42(7):1592-6. doi: 10.1128/AAC.42.7.1592. Antimicrob Agents Chemother. 1998. PMID: 9660989 Free PMC article.
Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer.
Jamis-Dow CA, Klecker RW, Sarosy G, Reed E, Collins JM. Jamis-Dow CA, et al. Cancer Chemother Pharmacol. 1993;33(1):48-52. doi: 10.1007/BF00686022. Cancer Chemother Pharmacol. 1993. PMID: 7505722
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.
Wilson WH, Jamis-Dow C, Bryant G, Balis FM, Klecker RW, Bates SE, Chabner BA, Steinberg SM, Kohler DR, Wittes RE. Wilson WH, et al. J Clin Oncol. 1995 Aug;13(8):1985-94. doi: 10.1200/JCO.1995.13.8.1985. J Clin Oncol. 1995. PMID: 7636539 Clinical Trial.
Suramin in adrenal cancer: modulation of steroid hormone production, cytotoxicity in vitro, and clinical antitumor effect.
La Rocca RV, Stein CA, Danesi R, Jamis-Dow CA, Weiss GH, Myers CE. La Rocca RV, et al. J Clin Endocrinol Metab. 1990 Aug;71(2):497-504. doi: 10.1210/jcem-71-2-497. J Clin Endocrinol Metab. 1990. PMID: 2380344
15 results
Jump to page